GeneDx Holdings Corp. Short-term Lease, Cost
GeneDx Holdings Corp. (WGS) reported Short-term Lease, Cost of $330.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-23.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ShortTermLeaseCost · last filed 2026-02-23
- GeneDx Holdings Corp. short-term lease, cost for the quarter ending 2023-06-30 was $200.00K, a 45.99% increase year-over-year.
- GeneDx Holdings Corp. short-term lease, cost for the quarter ending 2023-03-31 was $203.00K, a 20.12% increase year-over-year.
- GeneDx Holdings Corp. short-term lease, cost for the quarter ending 2022-12-31 was $709.00K.
- GeneDx Holdings Corp. short-term lease, cost for the quarter ending 2022-09-30 was $116.00K.
- GeneDx Holdings Corp. short-term lease, cost for fiscal 2025 was $330.00K, a 5.10% increase from fiscal 2024.
- GeneDx Holdings Corp. short-term lease, cost for fiscal 2024 was $314.00K, a 57.85% decline from fiscal 2023.
- GeneDx Holdings Corp. short-term lease, cost for fiscal 2023 was $745.00K, a 34.13% decline from fiscal 2022.
- GeneDx Holdings Corp. short-term lease, cost for fiscal 2022 was $1.13M.
| Period end | Short-term Lease, Cost 3 month | Short-term Lease, Cost 6 month | Short-term Lease, Cost 9 month | Short-term Lease, Cost 12 month |
|---|---|---|---|---|
| 2025-12-31 | $330.00K 10-K · filed 2026-02-23 | |||
| 2024-12-31 | $314.00K 10-K · filed 2026-02-23 | |||
| 2023-12-31 | $745.00K 10-K · filed 2026-02-23 | |||
| 2023-06-30 | $200.00K 10-Q · filed 2023-08-08 | $403.00K 10-Q · filed 2023-08-08 | $1.11M derived: sum of 3 quarters · filed 2024-02-23 | $1.23M derived: sum of 4 quarters · filed 2024-02-23 |
| 2023-03-31 | $203.00K 10-Q · filed 2023-05-09 | $912.00K derived: sum of 2 quarters · filed 2024-02-23 | $1.03M derived: sum of 3 quarters · filed 2024-02-23 | $1.17M derived: sum of 4 quarters · filed 2024-02-23 |
| 2022-12-31 | $709.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-23 | $825.00K derived: sum of 2 quarters · filed 2024-02-23 | $962.00K derived: sum of 3 quarters · filed 2024-02-23 | $1.13M 10-K · filed 2024-02-23 |
| 2022-09-30 | $116.00K 10-Q · filed 2022-11-14 | $253.00K derived: sum of 2 quarters · filed 2023-08-08 | $422.00K 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $137.00K 10-Q · filed 2023-08-08 | $306.00K 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | $169.00K 10-Q · filed 2023-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |